Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,364 | 40,593 | 36,439 | 52,911 | 65,374 |
| Marketable Securities | 18,297 | 21,657 | 30,599 | 28,005 | 27,450 |
| Receivables | 356 | 821 | 13,679 | 269 | 696 |
| TOTAL | $56,634 | $65,583 | $82,492 | $82,300 | $95,055 |
| Non-Current Assets | |||||
| PPE Net | 1,516 | 1,653 | 1,793 | 1,938 | 2,084 |
| Other Non-Current Assets | 8,093 | 8,531 | 5,547 | 5,391 | 5,447 |
| TOTAL | $9,609 | $10,184 | $7,340 | $7,329 | $7,531 |
| Total Assets | $66,243 | $75,767 | $89,832 | $89,629 | $102,586 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,812 | 4,812 | 4,812 | 3,923 | 2,590 |
| Accounts payable and accrued liabilities | 1,095 | 1,116 | 4,498 | 2,078 | 3,715 |
| Accrued Expenses | 10,251 | 8,534 | 12,852 | 15,667 | 14,243 |
| Other current liabilities | 1,823 | 1,754 | 893 | 888 | 883 |
| TOTAL | $17,981 | $16,216 | $23,055 | $22,997 | $22,237 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,861 | 8,064 | 9,267 | 10,470 | 11,673 |
| Deferred Revenues | N/A | N/A | N/A | 441 | 806 |
| Other Non-Current Liabilities | 6,411 | 6,900 | 4,572 | 4,809 | 5,036 |
| TOTAL | $13,277 | $14,964 | $13,838 | $15,270 | $16,701 |
| Total Liabilities | $31,258 | $31,180 | $36,893 | $38,267 | $38,938 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,979 | 57,979 | 57,980 | 57,989 | 57,989 |
| Common Shares | 58 | 58 | 58 | 58 | 58 |
| Retained earnings | -2,245,328 | -2,234,357 | -2,224,746 | -2,225,592 | -2,210,783 |
| Other shareholders' equity | -16,382 | -16,389 | -16,398 | -15,664 | -15,644 |
| TOTAL | $34,985 | $44,587 | $52,939 | $51,362 | $63,648 |
| Total Liabilities And Equity | $66,243 | $75,767 | $89,832 | $89,629 | $102,586 |